Longitudinal and multimodal auditing of tumor adaptation to CDK4/6 inhibitors in HR+ metastatic breast cancers
Allison Creason(Oregon Health & Science University), Jeremy Goecks(Moffitt Cancer Center), Cameron Watson(Harvard University), Gordon B. Mills(The University of Texas MD Anderson Cancer Center), Danielle Galipeau(Oregon Health & Science University), Lisa M. Coussens(Oregon Health & Science University), Christopher L. Corless(Oregon Health & Science University), Joe W. Gray(University of Newcastle Australia), Heidi S. Feiler(Oregon Health & Science University), Koei Chin(Oregon Health & Science University), Emek Demir(Memorial Sloan Kettering Cancer Center), Andrew Adey(Oregon Health & Science University), Jia‐Ren Lin(Harvard University), Brett Johnson(University of California, San Francisco), Kevin Hawthorne(Oregon Health & Science University), Peter K. Sorger(Harvard University Press), Nicholas E. Navin(The University of Texas MD Anderson Cancer Center), Julian Egger(Oregon Health & Science University), Zahi Mitri(Oregon Health & Science University), George Thomas(Oregon Health & Science University), Yu‐An Chen(Harvard University), Shamilene Sivagnanam(Oregon Health & Science University), Young Hwan Chang(Oregon Health & Science University)
Cited by 1
Related Papers
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
|Cancer Cell|2012|4.7k
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
|Science|2002|2.7k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k